Professor Stefano Boriani is a world-renowned orthopedic surgeon and author of unique surgical staging system of spinal tumors and tumor resection techniques. He has performed over 3,000 surgical procedures, written over 430 research articles, and invented a carbon fiber system for tumor reconstruction. He is also a professor at the Post-Graduate School of Orthopaedics at the University of Bologna, and a honorary member of several spine societies. He is also the founder of a non-profit association in Mozambique which supports medical activities and trains local surgeons.
Read moreProfessor Stefano Boriani is a world-renowned orthopedic surgeon and author of unique surgical staging system of spinal tumors and tumor resection techniques. He has performed over 3,000 surgical procedures, written over 430 research articles, and invented a carbon fiber system for tumor reconstruction. He is also a professor at the Post-Graduate School of Orthopaedics at the University of Bologna, and a honorary member of several spine societies. He is also the founder of a non-profit association in Mozambique which supports medical activities and trains local surgeons.
| Doctor's visit | price on request |
| Laminectomy | $10928.73 |
| Anterior cruciate ligament reconstruction | $11969.57 - $12489.98 |
| Discectomy | $10928.73 |
Head of the Orthopedics Department, Orthopedic Surgeon
Read moreHead of the Orthopedics Department, Orthopedic Surgeon
| Doctor's visit | price on request |
| Laminectomy | $10928.73 |
| Anterior cruciate ligament reconstruction | $11969.57 - $12489.98 |
| Discectomy | $10928.73 |
Orthopedist, Oncologist, Specialist in osteosarcoma treatment
Read moreOrthopedist, Oncologist, Specialist in osteosarcoma treatment
| Doctor's visit | price on request |
| Laminectomy | $10928.73 |
| Anterior cruciate ligament reconstruction | $11969.57 - $12489.98 |
| Discectomy | $10928.73 |
Spine Neurosurgeon
Read moreSpine Neurosurgeon
| Doctor's visit | price on request |
| Laminectomy | $10928.73 |
| Anterior cruciate ligament reconstruction | $11969.57 - $12489.98 |
| Discectomy | $10928.73 |
The Director of Doctor’s Equipe Clinic. The inventor of the Microfat system. Maxillofacial Surgery and Aesthetic Cosmetic Correction specialist.
Read moreThe Director of Doctor’s Equipe Clinic. The inventor of the Microfat system. Maxillofacial Surgery and Aesthetic Cosmetic Correction specialist.
Dr. Giuseppe Curigliano is the head of the Division of Early Drug Development at the European Institute of Oncology and an Associate Professor of Medical Oncology at the University of Milano in Italy. He is the founding member and scientific chair for the International Cardio-Oncology Society (ICOS) and has received the first ESO Umberto Veronesi Award in Vienna in 2017 and the Fellowship of the European Academy of Cancer Sciences in Paris in 2017.
Read moreDr. Giuseppe Curigliano is the head of the Division of Early Drug Development at the European Institute of Oncology and an Associate Professor of Medical Oncology at the University of Milano in Italy. He is the founding member and scientific chair for the International Cardio-Oncology Society (ICOS) and has received the first ESO Umberto Veronesi Award in Vienna in 2017 and the Fellowship of the European Academy of Cancer Sciences in Paris in 2017.
Nicoletta Colombo is a Director at the Ovarian Cancer Center at IEO, who has authored numerous publications in the field of gynecologic oncology and is a member of ASCO, SGO, and IGCS.
Read moreNicoletta Colombo is a Director at the Ovarian Cancer Center at IEO, who has authored numerous publications in the field of gynecologic oncology and is a member of ASCO, SGO, and IGCS.
Dr. Mohssen Ansarin is an oncologist specializing in head and neck cancer and is a funding member of SRS and AIOCC. He is an author and co-author of more than 50 articles, and is currently the Editor-in-Chief of ACTA Otolaryngologica.
Read moreDr. Mohssen Ansarin is an oncologist specializing in head and neck cancer and is a funding member of SRS and AIOCC. He is an author and co-author of more than 50 articles, and is currently the Editor-in-Chief of ACTA Otolaryngologica.
Filippo de Marinis is the Director of the Thoracic Oncology Unit at the European Centre for Oncology (Milan, Italy). The doctor leads clinical trials of new methods in the treatment of malignant tumors of the chest organs.
The doctor's experience is more than 30 years.
In 1978, De Marinis completed his studies in Pulmonology at the Sapienza University of Rome. From 1983 to 1986, he specialized in oncology at the Catholic University of the Sacred Heart in Rome. Filippo De Marinis then worked as a physician at the Carlo Forlanini Hospital and the Institute for Clinical Trials and Pneumophysiological Research. Since 2007, he has taught pulmonology at the Campus Biomedico private university in Rome and at the Sapienza University of Rome. Since 2013, the professor has been head of the Thoracic Cancer Unit at the European Oncology Center.
An appointment with Filippo de Marinis lasts from 40 to 60 minutes. During this time, the doctor collects the patient's medical history and compares it with the examination results. In order to establish an accurate diagnosis or plan an operation, the doctor will prescribe additional tests if necessary.
Professor de Marinis is the author of 250 scientific publications in 130 medical journals. As one of the leading experts in the treatment of lung cancer, he has spoken at 300 scientific congresses over the past 5 years.
The doctor participates in national and international clinical trials of new drugs.
Filippo de Marinis is the Director of the Thoracic Oncology Unit at the European Centre for Oncology (Milan, Italy). The doctor leads clinical trials of new methods in the treatment of malignant tumors of the chest organs.
The doctor's experience is more than 30 years.
In 1978, De Marinis completed his studies in Pulmonology at the Sapienza University of Rome. From 1983 to 1986, he specialized in oncology at the Catholic University of the Sacred Heart in Rome. Filippo De Marinis then worked as a physician at the Carlo Forlanini Hospital and the Institute for Clinical Trials and Pneumophysiological Research. Since 2007, he has taught pulmonology at the Campus Biomedico private university in Rome and at the Sapienza University of Rome. Since 2013, the professor has been head of the Thoracic Cancer Unit at the European Oncology Center.
An appointment with Filippo de Marinis lasts from 40 to 60 minutes. During this time, the doctor collects the patient's medical history and compares it with the examination results. In order to establish an accurate diagnosis or plan an operation, the doctor will prescribe additional tests if necessary.
Professor de Marinis is the author of 250 scientific publications in 130 medical journals. As one of the leading experts in the treatment of lung cancer, he has spoken at 300 scientific congresses over the past 5 years.
The doctor participates in national and international clinical trials of new drugs.
Barbara Alicia Jerechek is the Director of the Radiotherapy Unit at the European Oncology Centre in Milan and Professor of Radiation Oncology at the University of Milan. The doctor specializes in radiotherapy for all types of cancer and metastatic tumors.
Professor Jereczek received her medical degree from the University of Gdansk (Poland) in 1992. She completed advanced training in radiation oncology at the Warsaw Cancer Institute, the University of Milan, and the Beatson Cancer Centre at the University of Glasgow (UK). Since 1997, the doctor has been working as a radiotherapy specialist at the European Cancer Centre. Since 2015, she has been the head of the radiotherapy department at the clinic.
An appointment with Dr. Erechek to plan radiation therapy takes 30-50 minutes. The doctor reviews the patient's medical records and test results. She explains the diagnosis and talks about how further treatment will proceed. The doctor gives recommendations on how best to prepare for the course of procedures so that they are as comfortable as possible.
To get a consultation with Professor Erechek, leave a request on the Bookimed website. A coordinating doctor will contact you to agree on the date and time of the consultation.
Professor Barbara Alicia Ereczek is the author of 140 scientific publications.
Between 1999 and 2003, Professor Jereczek received 4 awards from the Medical University of Gdansk for scientific research in the field of oncology and radiotherapy.
Barbara Alicia Jerechek is the Director of the Radiotherapy Unit at the European Oncology Centre in Milan and Professor of Radiation Oncology at the University of Milan. The doctor specializes in radiotherapy for all types of cancer and metastatic tumors.
Professor Jereczek received her medical degree from the University of Gdansk (Poland) in 1992. She completed advanced training in radiation oncology at the Warsaw Cancer Institute, the University of Milan, and the Beatson Cancer Centre at the University of Glasgow (UK). Since 1997, the doctor has been working as a radiotherapy specialist at the European Cancer Centre. Since 2015, she has been the head of the radiotherapy department at the clinic.
An appointment with Dr. Erechek to plan radiation therapy takes 30-50 minutes. The doctor reviews the patient's medical records and test results. She explains the diagnosis and talks about how further treatment will proceed. The doctor gives recommendations on how best to prepare for the course of procedures so that they are as comfortable as possible.
To get a consultation with Professor Erechek, leave a request on the Bookimed website. A coordinating doctor will contact you to agree on the date and time of the consultation.
Professor Barbara Alicia Ereczek is the author of 140 scientific publications.
Between 1999 and 2003, Professor Jereczek received 4 awards from the Medical University of Gdansk for scientific research in the field of oncology and radiotherapy.
Professor Carlo Selmi is leading the Rheumatology and Clinical Immunology Unit at Humanitas Research Hospital.
Since 2009, he is the responsible of the Autoimmunity and Metabolic Laboratory, dedicated to the study of the possible mechanism linked to the progression of autoimmune diseases.
The research focuses on four main areas:
The team holds dedicated clinics also for, spondiloarthritis and connetcive tissue disease, and it is active in articular ultrasound, videocapillaroscopy, arthrocenthesis and joint injection of steroid or hyaluronic acid. The Division includes an inpatient clinic for complex cases. All group members are fluent in spoken and written English
Current Teaching Activity: Professor Selmi works as Assistant Professor of Rheumatology at the University of Milan since 2006. Furthermore, he holds a joint appointment as Assistant Professor of Medicine at the Division of Rheumatology of the University of California at Davis since 2005.
He is member of the American College of Rheumatology, American Association of Allergists and Immunologists, and the Italian Society of Rheumatology. He serves on the International Group for Research on Psoriatic Disease (GRAPPA) and the working group for autoantibody standardization within the ACR (ASC).
Publications: Selmi C[Author] - Search Results - PubMed (nih.gov)
Read moreProfessor Carlo Selmi is leading the Rheumatology and Clinical Immunology Unit at Humanitas Research Hospital.
Since 2009, he is the responsible of the Autoimmunity and Metabolic Laboratory, dedicated to the study of the possible mechanism linked to the progression of autoimmune diseases.
The research focuses on four main areas:
The team holds dedicated clinics also for, spondiloarthritis and connetcive tissue disease, and it is active in articular ultrasound, videocapillaroscopy, arthrocenthesis and joint injection of steroid or hyaluronic acid. The Division includes an inpatient clinic for complex cases. All group members are fluent in spoken and written English
Current Teaching Activity: Professor Selmi works as Assistant Professor of Rheumatology at the University of Milan since 2006. Furthermore, he holds a joint appointment as Assistant Professor of Medicine at the Division of Rheumatology of the University of California at Davis since 2005.
He is member of the American College of Rheumatology, American Association of Allergists and Immunologists, and the Italian Society of Rheumatology. He serves on the International Group for Research on Psoriatic Disease (GRAPPA) and the working group for autoantibody standardization within the ACR (ASC).
Publications: Selmi C[Author] - Search Results - PubMed (nih.gov)
Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Read moreProfessor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Prof. Alessandro Repici is the Director of the Gastroenterology and Digestive endoscopy Unit in Humanitas Research Hospital. Graduated in Medicine and Surgery in 1990 and the following year he won a scholarship at the Department of Gastroenterology Molinette hospital in Turin, where he began his practice in digestive endoscopy. In 1992, he worked with Prof. Claude Liguory as a fellow at the American Hospital in Paris.
In 1994 he became a specialist in Gastroenterology and Digestive Endoscopy at the University of Messina and worked in the Department of Gastroenterology, Ospedale Maggiore Molinette of Turin.
In the following years, he has been working at the Service of Digestive Endoscopy of Altona Hospital in Hamburg, directed by prof. Hagenmuller, and in the Department of Gastroenterology Molinette Hospital in Turin, directed by prof. Rizzetto. In 1999, he was a Research Fellow at the Center for Oncological and Operative Endoscopy of Wellsley Hospital in Toronto.
He teaches Gastroenterology and Digestive Endoscopy at the School of Specialization in Oncology since 2000, at the University of Turin since 2004 and Endoscopy Diagnostic Techniques and Operations at the School of Specialization in General Surgery I and II of the University of Turin.
The clinical activity and research of Prof. Repici mainly focuses on the development of new endoscopic techniques in the field of diagnosis and therapy, with particular attention to new methods of endoscopic removal of cancerous lesions and early in the palliation of advanced gastrointestinal malignancies.
Prof. Repici is coordinator, principal investigator and co-investigator in more than 50 studies, including phase II and III for FDA and EMA approval of new molecules and new instruments for diagnostic and operational endoscopy.
Prof. Repici collaborates on research projects in the field of endoscopy with the University of Rotterdam, in Haifa, in New York and with several Italian centers. He is a member of various national and international scientific society of Gastroenterology and Digestive Endoscopy.
Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=repici+alessandro
Read moreProf. Alessandro Repici is the Director of the Gastroenterology and Digestive endoscopy Unit in Humanitas Research Hospital. Graduated in Medicine and Surgery in 1990 and the following year he won a scholarship at the Department of Gastroenterology Molinette hospital in Turin, where he began his practice in digestive endoscopy. In 1992, he worked with Prof. Claude Liguory as a fellow at the American Hospital in Paris.
In 1994 he became a specialist in Gastroenterology and Digestive Endoscopy at the University of Messina and worked in the Department of Gastroenterology, Ospedale Maggiore Molinette of Turin.
In the following years, he has been working at the Service of Digestive Endoscopy of Altona Hospital in Hamburg, directed by prof. Hagenmuller, and in the Department of Gastroenterology Molinette Hospital in Turin, directed by prof. Rizzetto. In 1999, he was a Research Fellow at the Center for Oncological and Operative Endoscopy of Wellsley Hospital in Toronto.
He teaches Gastroenterology and Digestive Endoscopy at the School of Specialization in Oncology since 2000, at the University of Turin since 2004 and Endoscopy Diagnostic Techniques and Operations at the School of Specialization in General Surgery I and II of the University of Turin.
The clinical activity and research of Prof. Repici mainly focuses on the development of new endoscopic techniques in the field of diagnosis and therapy, with particular attention to new methods of endoscopic removal of cancerous lesions and early in the palliation of advanced gastrointestinal malignancies.
Prof. Repici is coordinator, principal investigator and co-investigator in more than 50 studies, including phase II and III for FDA and EMA approval of new molecules and new instruments for diagnostic and operational endoscopy.
Prof. Repici collaborates on research projects in the field of endoscopy with the University of Rotterdam, in Haifa, in New York and with several Italian centers. He is a member of various national and international scientific society of Gastroenterology and Digestive Endoscopy.
Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=repici+alessandro
Dr. Daniela Pini is the Head of the Cardio-respiratory rehabilitation Unit.
Medical areas of interest: Dr. Daniela Pini has been working and researching heart failure and has gained considerable experience in the management of advanced forms of this pathology. She is also very interested in the evaluation and "overall" management of patients suffering from this disease, which mainly affects elderly people and who already have other chronic diseases, which, if neglected, can easily impair the effectiveness of treatment for heart failure itself.
Research areas of interest: new therapies for advanced heart failure: replacement therapy of the heart with mechanical assistance devices to the circulation or heart transplant. New drugs and devices. Multidisciplinary patient management programs.
Further information of interest: thanks to the high competence of cardiosurgeons, electrophysiologists and hemodynamists, Humanitas can count, as a clinical cardiologist, on a team that allows it to offer the patient all the range of therapeutic options for heart failure.
From June 2000 to October 2001 she was Visiting Assistant Professor at the Cardiovascular Division Hospital of the University of Pennsylvania. During this period, she worked in the Heart Failure/Heart Transplantation Program, where she participated in the management of patients with advanced heart failure waiting for transplantation, dealing in particular with medical complications in patients with mechanical assistance devices. She has also worked with kidney, kidney-pancreas, pancreas-insulae, lung, liver and heart transplant teams, dealing with the multiple aspects of managing solid organ transplant recipients.
She worked in the Niguarda Ca' Granda Hospital, at the Cardiomyopathy and Heart Transplantation Service, dealing mainly with patients with advanced heart failure and undergoing a cardiac transplant.
Dr. Pini is a member of the coordination committee of the Decompensation Area of the National Association of Medical Hospital Cardiologists – ANMCO. In the last two years she has been mainly concerned on building a network of “heart failure clinics” on the national territory.
Read moreDr. Daniela Pini is the Head of the Cardio-respiratory rehabilitation Unit.
Medical areas of interest: Dr. Daniela Pini has been working and researching heart failure and has gained considerable experience in the management of advanced forms of this pathology. She is also very interested in the evaluation and "overall" management of patients suffering from this disease, which mainly affects elderly people and who already have other chronic diseases, which, if neglected, can easily impair the effectiveness of treatment for heart failure itself.
Research areas of interest: new therapies for advanced heart failure: replacement therapy of the heart with mechanical assistance devices to the circulation or heart transplant. New drugs and devices. Multidisciplinary patient management programs.
Further information of interest: thanks to the high competence of cardiosurgeons, electrophysiologists and hemodynamists, Humanitas can count, as a clinical cardiologist, on a team that allows it to offer the patient all the range of therapeutic options for heart failure.
From June 2000 to October 2001 she was Visiting Assistant Professor at the Cardiovascular Division Hospital of the University of Pennsylvania. During this period, she worked in the Heart Failure/Heart Transplantation Program, where she participated in the management of patients with advanced heart failure waiting for transplantation, dealing in particular with medical complications in patients with mechanical assistance devices. She has also worked with kidney, kidney-pancreas, pancreas-insulae, lung, liver and heart transplant teams, dealing with the multiple aspects of managing solid organ transplant recipients.
She worked in the Niguarda Ca' Granda Hospital, at the Cardiomyopathy and Heart Transplantation Service, dealing mainly with patients with advanced heart failure and undergoing a cardiac transplant.
Dr. Pini is a member of the coordination committee of the Decompensation Area of the National Association of Medical Hospital Cardiologists – ANMCO. In the last two years she has been mainly concerned on building a network of “heart failure clinics” on the national territory.
Medical areas of interest: Brain tumors, glioblastomas, low grade gliomas, brain metastases, meningiomas, neuromas, cavernous angiomas, brain aneurysms
Surgical treatment with brain mapping techniques, awake and minimally invasive surgery of all central nervous system tumors.
Surgical treatment of highly complex tumors of the skull base and cranio-cervical hinge: meningiomas, neuromas, craniopharyngiomas, brain stem tumors.
All the tumor pathologies described above are addressed after multidisciplinary multi-specialist evaluation.
The surgical approach is customized to the patient and to the type of lesion, making use of the most advanced intraoperative techniques for malignant brain tumors (neuronavigation, intraoperative neurophysiology, intraoperative CT) and more complex approaches (anterior, posterior and combined petroosectomies, minimally invasive accesses) for benign diseases of the skull base such as meningiomas and neuromas.
Research areas of interest: Experimental protocols in the treatment of glioblastomas
- Prospective protocols in the treatment of brain metastases
- Role of surgical removal and integrated treatments in glioblastomas and malignant brain tumors
- Intracranial meningiomas
- Cadaver lab dissection
Author of more than 60 scientific publications and 5 book chapters, he is member of Italian Society of Neurosurgery (SINCH).
In 2018 he joined the Scientific Committee of European Society of Neuroncology (EANO) and the Skull Base Surgery Committee of World Federation of Neurosurgical Society (WFNS).
Specialized training:
Prof. Pessina obtained his Degree in Medicine and Surgery in University of Insubria, Varese, where he also completed his Residency Program.
From 2007 to 2008 he covered the role of Clinical Fellow in Neurosurgery in Lausanne University Hospital, focusing on image-guided intrinsic brain tumors resection and vascular neurosurgery
In 2018 he covered the Skull Base fellow position in Lariboisiere Hospital, Paris, fully dedicating to skull base surgery and hands-on dissection practice and teaching.
Since 2022, he is Full Professor in Neurosurgery (MED/27) in Humanitas University
Additional information of interest:
Member of the Scientific Committee of the European Association of Neuroncology (EANO)
Publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=Pessina+Federico
Read moreMedical areas of interest: Brain tumors, glioblastomas, low grade gliomas, brain metastases, meningiomas, neuromas, cavernous angiomas, brain aneurysms
Surgical treatment with brain mapping techniques, awake and minimally invasive surgery of all central nervous system tumors.
Surgical treatment of highly complex tumors of the skull base and cranio-cervical hinge: meningiomas, neuromas, craniopharyngiomas, brain stem tumors.
All the tumor pathologies described above are addressed after multidisciplinary multi-specialist evaluation.
The surgical approach is customized to the patient and to the type of lesion, making use of the most advanced intraoperative techniques for malignant brain tumors (neuronavigation, intraoperative neurophysiology, intraoperative CT) and more complex approaches (anterior, posterior and combined petroosectomies, minimally invasive accesses) for benign diseases of the skull base such as meningiomas and neuromas.
Research areas of interest: Experimental protocols in the treatment of glioblastomas
- Prospective protocols in the treatment of brain metastases
- Role of surgical removal and integrated treatments in glioblastomas and malignant brain tumors
- Intracranial meningiomas
- Cadaver lab dissection
Author of more than 60 scientific publications and 5 book chapters, he is member of Italian Society of Neurosurgery (SINCH).
In 2018 he joined the Scientific Committee of European Society of Neuroncology (EANO) and the Skull Base Surgery Committee of World Federation of Neurosurgical Society (WFNS).
Specialized training:
Prof. Pessina obtained his Degree in Medicine and Surgery in University of Insubria, Varese, where he also completed his Residency Program.
From 2007 to 2008 he covered the role of Clinical Fellow in Neurosurgery in Lausanne University Hospital, focusing on image-guided intrinsic brain tumors resection and vascular neurosurgery
In 2018 he covered the Skull Base fellow position in Lariboisiere Hospital, Paris, fully dedicating to skull base surgery and hands-on dissection practice and teaching.
Since 2022, he is Full Professor in Neurosurgery (MED/27) in Humanitas University
Additional information of interest:
Member of the Scientific Committee of the European Association of Neuroncology (EANO)
Publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=Pessina+Federico